BODYGENICS Trademark

Trademark Overview


On Tuesday, May 2, 2023, a trademark application was filed for BODYGENICS with the United States Patent and Trademark Office. The USPTO has given the BODYGENICS trademark a serial number of 97917502. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, May 13, 2024. The BODYGENICS trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

vitamin and nutritional supplementation; hormone replacement therapy
bodygenics

General Information


Serial Number97917502
Word MarkBODYGENICS
Filing DateTuesday, May 2, 2023
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, May 13, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Pseudo MarkBODY GENICS
Goods and Servicesvitamin and nutritional supplementation; hormone replacement therapy

Classification Information


International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, May 31, 2023
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressPhoenix, AZ 85050

Trademark Events


Event DateEvent Description
Friday, May 5, 2023NEW APPLICATION ENTERED
Wednesday, May 31, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, May 13, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, May 13, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Sunday, January 28, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, January 27, 2024ASSIGNED TO EXAMINER
Sunday, January 28, 2024NON-FINAL ACTION WRITTEN
Sunday, January 28, 2024NON-FINAL ACTION E-MAILED